Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05049473
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:29.937346+00:00
Published At
2021-09-20T00:00:00+00:00
Record Updated At
2021-09-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mature B-Cell Leukemia Burkitt Type", "Burkitt Lymphoma (BL)", "Unclassifiable Lymphoma Between DCBL and BL"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-09-20"
protocolSection.identificationModule.nctId
"NCT05049473"
protocolSection.identificationModule.officialTitle
"Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14."
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Mature B-Cell Leukemia Burkitt Type (protocolSection.conditionsModule.conditions)
  • Burkitt Lymphoma (BL) (protocolSection.conditionsModule.conditions)
  • Unclassifiable Lymphoma Between DCBL and BL (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.